Mubadala announces expansion plan

[admin]

Mubadala Healthcare, a business unit of Mubadala Development Company (Mubadala), today announced plans to expand the existing services of Imperial College London Diabetes Centre (ICLDC) through the establishment of a second facility in Al Ain. This new Centre will provide world-class medical care for local residents in Al Ain and the surrounding region from the middle of next year.

The first Imperial College London Diabetes Centre facility opened in Abu Dhabi in 2006, following an agreement between Mubadala and Imperial College London to collaborate in the fields of healthcare, education and research. It was one of the first facilities to be established by Mubadala as part of its strategy to stimulate the development of a robust private healthcare infrastructure in the region.

The Centre is founded on the four pillars of treatment, training, public health and research, and provides the highest level of specialized and comprehensive patient care - from first diagnosis to the management of all the complications associated with diabetes. The expansion of services into Al Ain will be an extension of the same model of care.

The International Diabetes Federation has estimated that 18.7% of the UAE population is living with Diabetes and according to the Centre's figures, an average of 15% of their patients reside outside Abu Dhabi in Al Ain.

"It is testament to the excellent work carried out at the Centre over the past four years that we are now able to replicate the same model of care for patients living outside the capital. I am delighted to build upon our partnership with Imperial College London with a second facility and improve access to world-class healthcare in the region,"


said Suhail Mahmood Al Ansari, Associate Director of Mubadala Healthcare and Chairman of ICLDC.

In its first four years of operation, Imperial College London Diabetes Centre has achieved tremendous operational success with more than 27,000 registered patients, 80,000 one-to-one consultations conducted by the Centre's specialist public health team, and an award-winning public health awareness campaign, 'Diabetes. Knowledge. Action' that has reached out to countless others across the Emirates.

"This new facility will allow us to become an integral part of the Al Ain community," said Dr Maha Barakat, Medical and Research Director, Imperial College London Diabetes Centre. "Improved local access to our services will make it easier for patients to receive treatment, prevent the complications associated with diabetes, and ultimately live healthier lives."